本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

14.30
-0.5500-3.70%
盤前14.01-0.2900-2.03%07:09 EDT
成交量:48.54萬
成交額:698.14萬
市值:15.06億
市盈率:-9.22
高:14.86
開:14.86
低:14.21
收:14.85
52周最高:38.12
52周最低:10.60
股本:1.05億
流通股本:6,053.37萬
量比:0.82
換手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-1.5508
每股收益(LYR):-1.4480
淨資產收益率:-27.41%
總資產收益率:-19.06%
市淨率:2.56
市盈率(LYR):-9.88

資料載入中...

2022/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/05

重要事件披露

8-K - Current report
2021/12/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/13

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report